IL10 and synovial sarcoma: These findings suggested that IL-27 gene deficiency aggravated SS-like symptoms in NOD mice, and exogenous IL-27 treatment could reverse the decreasing salivary flow rate, splenic CD4+IL-10+ T cells, and serious inflammation.